Diagnostic procedures and treatment of patients with myelodysplastic syndromes (MDS) in outpatient clinics. Results of the outpatient MDS registry

被引:0
|
作者
Schmitz, S. [1 ]
Boettger, I. [1 ]
Schnell, R. [2 ]
Sauer, A. [3 ]
Linde, H. [3 ]
Severin, K. [1 ]
Germing, U. [4 ]
Steinmetz, T. [1 ]
机构
[1] Onkol Gemeinschaftspraxis, Hematol, Cologne, Germany
[2] Gemeinschaftspraxis, Onkol, Pioh, Frechen, Germany
[3] Onkol Gemeinschaftspraxis, Hamatol, Potsdam, Germany
[4] Univ Dusseldorf, Hamatol, Dusseldorf, Germany
关键词
D O I
10.1016/S0145-2126(13)70251-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-204
引用
收藏
页码:S115 / S115
页数:1
相关论文
共 50 条
  • [31] HYPERFERRITINEMIA IS ASSOCIATED WITH IMPAIRED SURVIVAL IN PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES RESULTS FROM THE FIRST POLISH MDS REGISTRY
    Waszczuk-Gajda, A.
    Dwilewicz-Trojaczek, J.
    Madry, K.
    Drozd-Sokolowska, J.
    Stella-Holowiecka, B.
    Machowicz, R.
    Mital, A.
    Obara, A.
    Szmigielska-Kaplon, A.
    Sikorska, A.
    Kolkowska-Lesniak, A.
    Subocz, E.
    Mendrek, W.
    Szczepanska, M.
    Biedron, M.
    Jachalska, A.
    Wasilewska, E.
    Wojciechowska, M.
    Guzicka-Kazmierczak, R.
    Wiater, E.
    Kopacz, A.
    Katinas, K.
    Kruger, W.
    Dawidowska, A.
    Zawirska, D.
    Salamanczuk, Z.
    Swiderska, A.
    Gornik, S.
    Sedzimirska, M.
    Soroka-Wojtaszko, M.
    Nowicki, A.
    Jedrzejczak, W. W.
    HAEMATOLOGICA, 2015, 100 : 722 - 722
  • [32] Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
    Kasprzak, Annika
    Andresen, Julia
    Nachtkamp, Kathrin
    Kuendgen, Andrea
    Schulz, Felicitas
    Strupp, Corinna
    Kobbe, Guido
    Mackenzie, Colin
    Timm, Joerg
    Dietrich, Sascha
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2024, 16 (04)
  • [33] Guideline for the treatment of myelodysplastic syndromes (MDS) in South Africa
    Louw, V. J.
    Bassa, F.
    Chan, S. W.
    Dreosti, L.
    du Toit, M.
    Ferreira, M.
    Gartrell, K.
    Gunther, K.
    Jogessar, V.
    Littleton, N.
    Mahlangu, J.
    McDonald, A.
    Patel, M.
    Pool, R.
    Ruff, P.
    Schmidt, A.
    Sissolak, G.
    Swart, A.
    Verburgh, E.
    Webb, M. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (12): : 900 - 906
  • [34] LENALIDOMIDE TREATMENT IN 20 PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS). MULTICENTER REGISTRY
    Arrizabalaga, B.
    Del Orbe, R.
    Zamora, M.
    Ardanaz, M.
    Arguinano, J.
    Sirvent, M.
    Atucha, L.
    Atucha, J.
    Insunza, A.
    Montes, C.
    Campeny, A.
    HAEMATOLOGICA, 2013, 98 : 585 - 585
  • [35] Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS)
    List, AF
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : S31 - S35
  • [36] Incidence, Treatment and Course Of Disease Of Patients With del5q Myelodysplastic Syndrome (MDS) In The "pre-lenalidomide" Era In Germany. Data From The German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Snide
    Sauer, Annette
    Linck, Dominick
    Severin, Kai
    Germing, Ulrich
    Gattermann, Norbert
    Schmitz, Stephan
    BLOOD, 2013, 122 (21)
  • [37] Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry
    Madry, Krzysztof
    Lis, Karol
    Fenaux, Pierre
    Bowen, David
    Symeonidis, Argiris
    Mittelman, Moshe
    Stauder, Reinhard
    Cermak, Jaroslav
    Sanz, Guillermo
    Hellstrom-Lindberg, Eva
    Langemeijer, Saskia
    Malcovati, Luca
    Germing, Ulrich
    Holm, Mette Skov
    Guerci-Bresler, Agnes
    Culligan, Dominic
    Sanhes, Laurence
    Kotsianidis, Ioannis
    van Marrewijk, Corine
    Crouch, Simon
    de Witte, Theo
    Smith, Alex
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (04) : 451 - 461
  • [38] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    CALAVREZOS, A
    SEEGER, D
    KUSE, R
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
  • [39] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [40] A tobacco cessation program in outpatient substance abuse treatment clinics.
    Nahvi, S.
    Cooperman, N. A.
    Arnsten, J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 195 - 195